Alexander Menzies

Alexander Menzies at Melanoma Institute Australia is an expert in melanoma treatment sequencing — a critical question of whether immunotherapy or targeted BRAF/MEK inhibition should be used first for patients eligible for both. His research analyzing real-world outcomes and conducting prospective trials comparing sequencing strategies has contributed to clinical decision-making in BRAF-mutated advanced melanoma.